| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Revenue | $52.0B | $44.0B | $37.3B | $31.9B | $17.5B | $11.1B | $14.1B |
| Cost of Revenue | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — |
| R&D Expense | $3.4B | $3.1B | $3.2B | $2.8B | $2.1B | $2.2B | $4.8B |
| SG&A Expense | — | — | — | — | — | — | — |
| Operating Income | $5.6B | $2.8B | $1.1B | $-1.8B | $-3.8B | $-4.9B | $-8.6B |
| Net Income | $10.1B | $9.9B | $1.9B | $-9.1B | $-0.5B | $-6.8B | $-8.5B |
| EPS (Basic) | $4.82 | $4.71 | $0.93 | $-4.64 | $-0.26 | $-3.86 | $-6.81 |
| EPS (Diluted) | $4.73 | $4.56 | $0.87 | $-4.65 | $-0.29 | $-3.86 | $-6.81 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Total Assets | $61.8B | $51.2B | $38.7B | $32.1B | $38.8B | $33.3B | $31.8B |
| Current Assets | $14.0B | $12.2B | $11.3B | $9.2B | $8.8B | $9.9B | $13.9B |
| Cash & Equivalents | $7.1B | $5.9B | $4.7B | $4.2B | $4.3B | $5.6B | $10.9B |
| Total Liabilities | $33.7B | $28.8B | $26.0B | $23.6B | $23.4B | $19.5B | $16.6B |
| Current Liabilities | $12.3B | $11.5B | $9.5B | $8.9B | $9.0B | $6.9B | $5.6B |
| Stockholders' Equity | $27.0B | $21.6B | $11.2B | $7.3B | $14.5B | $12.3B | $14.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $10.1B | $7.1B | $3.6B | $0.6B | $-0.4B | $-2.7B | $-4.3B |
| Investing Cash Flow | $-3.6B | $-3.2B | $-3.2B | $-1.6B | $-1.2B | $-2.9B | $-0.8B |
| Capital Expenditures | $0.3B | $0.2B | $0.2B | $0.3B | $0.3B | $0.6B | $0.6B |
| Financing Cash Flow | $-5.7B | $-2.1B | $-0.1B | $0.0B | $1.8B | $1.4B | $8.9B |